Circio Competitors and Similar CompaniesClear all
Circio's competitors and similar companies include Zymeworks, Neovii, Alpha Tau Medical and Silverback Therapeutics.
 Circio Circio Holding (formerly known as Targovax) is a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  Alpha Tau Medical Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. |  Silverback Therapeutics Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases. | |
Founding Date | Founding Date 2010 | Founding Date 2003 | Founding Date 2003 | Founding Date 2016 | Founding Date 2016 |
Type | Type Public | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Lysaker, NO HQ Espoo, FI Ullern, NO | Locations Vancouver, CA HQ Seattle, US | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Tel Aviv-Yafo, IL HQ Boston, US | Locations Seattle, US HQ |
Employees | Employees 7 | Employees 45519% increase | Employees 1193% increase | Employees 1041% increase | Employees 9067% increase |
Valuation ($) | Valuation ($) 3.4 m | Valuation ($) 973.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 550.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $106m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $1.3m (FY, 2022) |
Net income | Net income (kr45.9m) (FY, 2025) | Net income ($81.1m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($34.7m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised $ 16.9m | Total funding raised $ 125.9m | Total funding raised N/A | Total funding raised $ 55m | Total funding raised $ 211m |
For sources of this data, please see the company profile
View Company Profiles
Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyNeovii
HQ
Rapperswil-Jona, CH
Employees
119↑ 3% increase
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View companyAlpha Tau Medical
HQ
Tel Aviv-Yafo, IL
Employees
104↑ 1% increase
Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.
View companySilverback Therapeutics
HQ
Seattle, US
Employees
90
Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
View company